Video 4
Disclaimer: Individual results vary. Local etanercept treatment for the indications below is off-label. Please see the Legal Disclaimer. Maintenance dosing, usually weekly, but sometimes as little as monthly, is necessary for optimal effect. The methods of local etanercept treatment utilized for these patients are patented inventions of the INR[1].
Rapid improvement in speech following anti-TNF initiation at the INR (2008) video length 4:59

Rapid improvement in speech in primary progressive aphasia following local etanercept. For the published results please see Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanisms. Edward Tobinick MD. Medscape Journal of Medicine, Neurology and Neurosurgery Clinical Cases 2008 June 10; 10(6):135. This video was included as part of the peer-reviewed, published, scientific article.
INR 100 UCLA Medical Plaza, Suites 205-210 Los Angeles (310) 824-6199 Orange County: 361 Hospital Road, Suite 428 Newport Beach

Copyright ©2010, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved. [1]U.S. patents 6,537,549; 6,982,089; 7,214,658; 7,629,311; Australian patent 758,523; and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC. Please see the medical and legal disclaimer.
<Map and Directions><Appointments><Physician Training Program><Terms of Use><Memory Disorders Program-detailed brochure (PDF)><Videos>